The Caudal-related homeodomain transcription factor Cdx2 plays a key role in intestinal cell fate determination. Reduction of Cdx2 expression is a feature of many human colon carcinomas and inactivation of one cdx2 allele facilitates the development of invasive adenocarcinoma in the murine colon. Here, we investigated the post-translational regulation of Cdx2. We showed that various forms of Cdx2 coexist in the intestine and colon cancer cell lines, some of them being phosphorylated forms. We found that cyclin-dependent kinase 2 phosphorylated Cdx2 in vitro and in vivo. Using site-specific mutagenesis, we identified serine 281 as a new key residue for Cdx2 phosphorylation. Intriguingly, serine 281 belongs to a conserved motif of four evenly spaced serines (the 4S motif) similar to the one controlling b-catenin degradation by the proteasome pathway. A nonphosphorylated mutant Cdx2 lacking the 4S motif (4S>A) exhibited reduced polyubiquitination upon proteasome inhibition and increased stability compared to wild-type Cdx2. In addition, we found that this mutant was less efficient to suppress colony formation than wild-type Cdx2. Thus, our data highlight a novel post-translational mechanism controlling Cdx2 degradation via phosphorylation and polyubiquitination, which may be of importance for intestinal development and cancer.
Introduction
The single epithelium lining the gut is continually renewed with a fast turnover by a process involving cell generation and proliferation from stem cells located in crypts, progressive intestinal differentiation as cells migrate towards the epithelial surface, and extrusion at the apex of the epithelium. Tight temporal and spatial control of these cellular processes is required to maintain intestinal homeostasis, and its alteration leads to colorectal cancer, which is a major disease worldwide .
Transcription factors encoded by homeobox genes play a major role in antero-posterior patterning and cell fate determination during embryogenesis and as such are often found mutated or dysregulated in a wide variety of congenital human malformations and metabolic diseases. There is also increasing evidence that homeodomain-containing transcription factors control the equilibrium between cell growth and differentiation and that their dysregulation contributes to tumorigenesis (Cillo et al., 2001; Abate-Shen, 2002) . It is the case for Cdx2, one of the three mammalian orthologs of the Drosophila Caudal , which is widely expressed in the posterior part of the embryo during early development, but becomes restricted to the intestinal epithelium later in fetal life and in the adult (Beck et al., 1995; Silberg et al., 2000) . Overexpression of Cdx2 in various intestinal cell lines reduces proliferation and promotes differentiation (Suh and Traber, 1996; Lorentz et al., 1997; Mallo et al., 1998) . Accordingly, Cdx2 binds to and transactivates the promoter of intestine-specific genes involved in the digestive function (Suh et al., 1994; Taylor et al., 1997b; Fang et al., 2000; Yamamoto et al., 2003) , as well as genes involved in cellular adhesion (Hinoi et al., 2002; Sakaguchi et al., 2002) and in inhibition of proliferation .
Cdx2 exerts a homeotic function as haploinsufficiency in cdx2 þ /À heterozygotes leads to homeotic developmental defects (Chawengsaksophak et al., 1997) , including the formation of foregut-like heteroplasia in the proximal colon (Beck et al., 1999; Tamai et al., 1999) , whereas conversely the ectopic expression in the stomach causes intestinalization of the gastric mucosa (Mutoh et al., 2002) . Thus, Cdx2 plays a major role in defining intestinal identity along the developing digestive tract. Besides, we and others have recently demonstrated a role for Cdx2 in colon cancer. Indeed, the altered expression of Cdx2 in cdx2 þ /À mice promotes tumor progression in animal models mimicking either sporadic colorectal cancers (Bonhomme et al., 2003) or genetically predisposed polyposis (Aoki et al., 2003) . Hence, Cdx2 is considered as a tumor suppressor in the colon. This conclusion is in agreement with the decrease of Cdx2 expression reported in colorectal cancer patients (Ee et al., 1995) and with the fact that overexpression of Cdx2 reduces the malignancy of human colon cancer cells (Mallo et al., 1998) .
Given the importance of Cdx2 for normal development and tumorigenesis of the gut, both its expression and activity need to be tightly regulated. Transcriptional regulation of cdx2 has been extensively studied (Lorentz et al., 1997 (Lorentz et al., , 1999 Domon-Dell et al., 2002; Kim et al., 2002; Brabletz et al., 2004) . Interestingly, it has also been proposed recently that Cdx2 is post-transcriptionally regulated. Indeed, phosphorylation by ERK kinases of serine 60 within the amino-terminal transactivation domain reduces its transcriptional activity (Rings et al., 2001) whereas inversely, phosphorylation of Cdx2 by the kinase p38 accompanies cell differentiation and enhances its transcriptional activity (Houde et al., 2001) . In the present study, we have further investigated Cdx2 phosphorylation. We identified a conserved motif of four evenly spaced serines, the 4S motif, which is required for phosphorylation by cyclin-dependent kinase 2 (CDK2). In addition, we provided evidence that Cdx2 can be ubiquitinated and degraded by the proteasome pathway, and that the 4S motif controls polyubiquitination and stability of Cdx2. Finally, we showed that this motif is important for Cdx2 function.
Results

Various forms of Cdx2 coexist in the intestine
In the course of previous studies, we had observed that Cdx2 exhibited a complex band pattern around 36 kDa in the intestinal mucosa and in intestinal cell lines (Supplementary information Figure 1 ). To check if some of the bands corresponded to phosphorylated forms of Cdx2, we performed alkaline phosphatase treatments on Caco-2 cells and on mouse jejunum extracts before Western blot analysis. Phosphatase treatment drastically altered the Cdx2 band pattern. Indeed, the upper bands had totally disappeared after only 1 h of treatment, whereas the lower bands were still present after 1 h, or even 16 h of treatment (Figure 1 and data not shown). Importantly, no change in the Cdx2 band pattern was observed when phosphatase treatment was performed in the presence of phosphatase inhibitors, confirming that the alteration was actually due to phosphatase activity (Figure 1) . Thus, various forms of Cdx2, including nonphosphorylated and phosphorylated forms, coexist in the intestinal epithelium and in intestinal cells in culture.
Serine 281 is required for Cdx2 phosphorylation
Examination of Cdx2 peptidic sequence revealed consensus phosphorylation sites for known kinases (Obenauer et al., 2003) . Using site-directed mutagenesis, we generated various HA-tagged Cdx2 mutants lacking some of these potential phosphorylation sites. The mutants were overexpressed in HCT 116 cells (or H293 cells with identical results, data not shown) and their migration through SDS-PAGE was examined by Western blot. Most of the mutants migrated similarly to the wild-type Cdx2 protein (Figure 2a ), exhibiting two major bands. In contrast, the HA-tagged Cdx2 mutant 3S>A (serines 281, 285 and 289 replaced by alanines) migrated very differently, displaying only one, fast migrating, major band. Noteworthy, dephosphorylation of HA-tagged wild-type Cdx2 by alkaline phosphatase treatment changed the two-bands pattern into a single major band that migrated like the mutant 3S>A (Figure 2b) , and the pattern of this mutant was not affected by phosphatase alkaline treatment (Figure 2b) . Hence, the similar migration of the 3S>A mutant and of dephosphorylated wild-type Cdx2 strongly suggests that amino-acids S281, S285 and/or S289 are important for Cdx2 most noticeable phosphorylation.
The amino-acids S281, S285 and S289 located downstream of the DNA-binding homeodomain at the Cterminal end of Cdx2, are part of a motif of four evenly spaced serines, designed hereafter as the 4S motif, that is highly conserved among the Cdx2 proteins of different species (Figure 2c ). Intriguingly, a similar arrangement of four evenly-spaced serines plays a key role in the phosphorylation and degradation of b-catenin by the proteasome pathway (Aberle et al., 1997) . We generated the single-point mutants S281A, S285A, S289A, S293A, as well as the compound mutant 4S>A (serines 281, 285, 289 and 293 replaced by alanines), and examined their migration on SDS-PAGE. Figure 2d shows that the HA-tagged Cdx2 S281A and 4S>A mutants exhibited one major fast migrating band like the 3S>A mutant, whereas the other mutants displayed two major bands like wild-type Cdx2. As expected, Flag-tagged versions of the mutants S281A and 4S>A also migrated as one fast-moving band on SDS-PAGE, unlike the two major bands shown by Flag-tagged wildtype Cdx2 (Figure 2e ), confirming that migration was independent of the tagged sequence. To further address if phosphorylation of the 4S motif can modify Cdx2 migration pattern, we created phospho-mimick mutants in which serines were replaced by glutamic acids. We Regulation of Cdx2 stability by phosphorylation I Gross et al constructed the Flag-tagged single-point mutant S281E, as well as the compound mutants 2S>E (serines 281 and 285 replaced by glutamic acids) and 4S>E (serines 281, 285, 289 and 293 changed into glutamic acids). All these mutants migrated as one major single band, but the distance of migration was different from one mutant to the other. Indeed, while the Cdx2 mutant 2S>E migrated like the major phosphorylated band of Flagtagged wild-type Cdx2, the S281E mutant migrated at an intermediate position between the two major bands of wild-type Cdx2, and the compound 4S>E mutant exhibited an even slower-migrating band than the major phosphorylated form of wild-type Cdx2 ( Figure 2e ).
Collectively, these results demonstrate that the electrophoresis pattern of Cdx2 is altered by single and/or compound mutations that prevent or mimick phosphorylation in the 4S motif and indicate that S281 is required for Cdx2 phosphorylation.
CDK2 phosphorylates Cdx2 through the 4S motif
Since S281 is located in a consensus phosphorylation site for ERK, p38, GSK-3b and CDK (Obenauer et al., 2003) , we tested the ability of these kinases to phosphorylate Cdx2. Results (Supplementary information Figure 2a ) indicated that ERK2, p38a and GSK-3b can phosphorylate Cdx2 in vitro and that the 4S motif is required for phosphorylation by GSK-3b and p38a but dispensable for phosphorylation by ERK2. However, the band pattern of Cdx2 was neither affected by overexpression of wild-type or mutant forms of GSK-3b, ERK1 or p38a, nor by cell treatment with pharmacological inhibitors of these kinases (Supplementary information Figure 2b -f). When immunoprecipitated wild-type HA-tagged Cdx2 was incubated with recombinant CDK2 and radioactive ATP for in vitro phosphorylation, a signal was observed at around 36 kDa, the size of Cdx2 (Figure 3a) . No signal was observed without kinase or without Cdx2. Importantly, almost no radioactivity was detected when immunoprecipitated Cdx2 4S>A mutant was used as substrate instead of wild-type Cdx2 ( Figure 3a) . Next, we checked if CDK2 is involved in the phosphorylation of Cdx2 in vivo. For this, HCT 116 cells were transfected with wild-type Flag-tagged Cdx2 alone or in combination with wild-type or dominantnegative forms of CDK2. Upon coexpression of wildtype CDK2, the intensity of the slow migrating band was enhanced. Conversely, upon coexpression of dominant-negative CDK2, the intensity of the fast migrating band was increased (Figure 3b ). To strengthen these results, we checked the migration of endogenous Cdx2 in Caco-2/TC7 cells treated with Roscovitine, a pharmacological inhibitor of CDK. Consistent with the above results, the Cdx2 band pattern was altered by Roscovitine treatment, leading to decreased intensity of the slowest migrating bands (Figure 3c ). In addition, Roscovitine similarly altered the band pattern of HA-Cdx2 transfected into Caco-2 and H293 cells (Supplementary Figure 2e, f) .
Altogether, these data indicate that GSK-3b, p38a and CDK2 can phosphorylate Cdx2 through the 4S Regulation of Cdx2 stability by phosphorylation I Gross et al motif in vitro, but only CDK2 was shown to be active in vivo, using a dominant-negative mutant and an inhibitor of this kinase.
The 4S motif modulates the transcriptional activity of Cdx2
We then examined the impact of phosphorylation on the transcriptional activity of Cdx2. First, we compared the ability of overexpressed Cdx2 wild-type and 4S>A mutant to stimulate the expression of luciferase driven by Cdx2-responsive promoters. Figure 4a shows the results obtained with HCT 116 cotransfected with IPAL-Luc (Taylor et al., 1997a) and increasing doses of the plasmids encoding Cdx2 wild-type or the mutant 4S>A. As expected, wild-type Cdx2 stimulated expression of this reporter in a dose-dependent manner. Noticeably, the Cdx2 mutant 4S>A was more efficient (40-100%) than wild-type Cdx2 at all doses tested. We also examined the transcriptional activities of the other Cdx2 mutants on the same reporter (Figure 4b) . Remarkably, only the Cdx2 mutant 3S>A displayed enhanced activity, whereas the single mutants, even the S281A, behaved like wild-type Cdx2. Similar results (data not shown) were obtained with a Lactase reporter gene (Fang et al., 2000) and to a lower degree with a Sucrase-isomaltase reporter gene (Rodolosse et al., 1996) . Thus, these data support a role of the 4S motif, and not only of the S281 required for phosphorylation, in modulating Cdx2 transcriptional activity.
To strengthen these results, we also examined directly the ability of wild-type and mutant Cdx2 to activate claudin-2) were normalized using the Ct of 18S ribosomal RNA. Results correspond to the mean þ /À standard deviation of normalized duplicates. They are presented as % and were calculated relative to the expression of the gene of interest in the absence of Cdx2 which was set at 100. Similar results were obtained in two independent experiments Regulation of Cdx2 stability by phosphorylation I Gross et al endogenous expression of Cdx2 target genes. For this purpose, HCT 116 cells were transfected with plasmids encoding Cdx2 wild-type or 4S>A mutant and total RNA was extracted and subjected to quantification by real-time RT-PCR. Figure 4c shows the results obtained for muc-2 mRNA, a Cdx2 target gene characteristic of differentiated intestinal goblet cells (Yamamoto et al., 2003) . As expected, expression of wild-type Cdx2 led to a 2.4-fold increase in muc-2 mRNA. Noticeably, the Cdx2 mutant 4S>A generated a 35% stronger increase in muc-2 expression than wild-type Cdx2. The same effect was obtained for claudin-2 mRNA, a Cdx2 target gene involved in tight junctions between adjacent enterocytes (Sakaguchi et al., 2002 , Figure 4d ). Altogether these results suggest that the 4S motif can modulate the transcriptional effect of Cdx2.
The 4S motif regulates Cdx2 stability via polyubiquitination
Incidentally, we observed that transfection of limited amounts of Cdx2-expressing vectors (10 times less than usual) consistently led to stronger signals in Western blot for the Cdx2 mutants 4S>A (Figure 5a) (Figure 5b ) and amounts were quantified in three independent experiments using NIH image software (Figure 5c ). Strikingly, after 6 h of cycloheximide treatment, wild-type Cdx2 protein amount had dropped to half of its initial amount, but there was almost no change in the protein amount of the Cdx2 mutant 4S>A. After 14 h of cycloheximide treatment, there was still a higher amount of mutant Cdx2 compared to the wild-type protein. This showed that wild-type Cdx2 is less stable (half-life: 672 h) than the Cdx2 mutant 4S>A (half-life: 1470.7 h), and that the 4S motif of Cdx2 negatively regulates its stability. Since a four serines motif is involved in phosphorylation and polyubiquitination-dependent degradation of b-catenin by the proteasome, we investigated if a related mechanism might regulate Cdx2 stability via the similarly arranged 4S motif. First, intracellular proteolysis was blocked within intestinal HT29 cells using the proteasome inhibitor MG132. As shown in Figure 5d , HT29 cells express only a limited amount of endogenous Cdx2, which was clearly increased upon MG132 treatment. Similarly, the amount of overexpressed HAtagged Cdx2 was enhanced by proteasome inhibition and the signal was concentrated in the slower migrating, phosphorylated form, of Cdx2 (Figure 5d ). Thus, Cdx2 is degraded by the proteasome pathway.
Given the different half-lives of wild-type and mutant 4S>A Cdx2, we next examined if the 4S motif could affect ubiquitination of Cdx2. HCT 116 were cotransfected with plasmids encoding wild-type or mutant 4S>A Flag-tagged Cdx2 and HA-tagged ubiquitin. Cells were treated or not with a proteasome inhibitor before lysis and Cdx2 was specifically immunoprecipitated from the lysates with the anti-Flag antibody. Next, immunoprecipitates were analysed by Western blot with the anti-Flag antibody to detect total Cdx2 (Figure 5e , left panel) and with the anti-HA antibody to detect ubiquitinated Cdx2 (Figure 5e, right panel) . Upon inhibition of the proteasome, a characteristic smear of polyubiquitination was observed when wild-type Cdx2 had been cotransfected with HA-tagged ubiquitin. No smear was detected in the control samples (no Flag-Cdx2 or no HA-ubiquitin) or without inhibition of the proteasome. Thus, wild-type Cdx2 can indeed be ubiquitinated and degraded by the proteasome pathway. However, in contrast to wild-type Cdx2, almost no smear was detected for the Cdx2 mutant 4S>A (Figure 5e ). Therefore, Cdx2 is polyubiquitinated in intestinal cells and mutation at the 4S site, which prevents phosphorylation, also inhibits polyubiquitination.
The 4S motif is important for the activity of Cdx2
Finally, to test the functional importance of the 4S motif, we performed a colony formation assay since Cdx2 overexpression was previously shown to reduce cell growth (Suh and Traber, 1996; Lorentz et al., 1997; Mallo et al., 1998) . HCT 116 cells were transfected with wild-type or mutant (4S>A) Flag-tagged Cdx2, selected with G418 and after 2 weeks colonies formed were scored. In this assay, wild-type Cdx2 was able to reduce the number of colonies formed by B50% compared to control (Figure 6a, b) . Remarkably, the Cdx2 mutant 4S>A was less efficient than wild-type Cdx2, only reducing the number of colonies formed by 30% compared to control. Thus, lack of phosphorylation through the 4S motif is able to significantly hamper Cdx2 activity in the colony formation assay.
Discussion
Post-translational modification is a common mechanism to regulate transcription factors. Phosphorylation of homeodomain transcription factors has been reported to change transcriptional activity (Jaffe et al., 1997) , nucleocytoplasmic shuttling (Macfarlane et al., 1999) or to regulate proteolysis (Zhu and Kirschner, 2002) . In the present work, we provide evidence (1) that Cdx2 is phosphorylated by CDK2 through a motif located downstream of the homeodomain and containing four serines like the one controlling b-catenin stability; (2) that preventing phosphorylation through this site blocks polyubiquitination of Cdx2 and stabilizes the protein; (3) that this impacts on the overall cell behavior.
Similarly to many transcription factors (Boulikas, 1995) , Cdx2 is likely to contain multiple phosphorylation sites that either positively or negatively modulate its activity in response to different signaling pathways. Two studies had already reported the occurrence of p38a and ERK-dependent phosphorylation of Cdx2 within the amino-terminal region, upstream of the DNA-binding homeodomain (Houde et al., 2001; Rings et al., 2001) . Here, we show that phosphorylation of Cdx2 also requires the 4S motif located downstream of the homeodomain. The single mutant S281A, as well as the compound mutants 3S>A and 4S>A, migrate as a single band like dephosphorylated wild-type Cdx2, whereas the other single mutants S285A, S291A and S293A migrate as two bands like the wild-type protein.
Each of the phospho-mimicking mutants S281E, 2S>E
and 4S>E also exhibit a specific migration pattern. Collectively, these results suggest that, while S281 is required for phosphorylation of Cdx2, combinations of other serines may be phosphorylated within the 4S motif. At the functional level, we found that only the compound mutants 3S>A and 4S>A, but none of the single mutants, even S281A, behave differently from wild-type Cdx2 on downstream target promoters. This supports that the activity of Cdx2 is indeed modulated by combinations of multiple phosphorylations at the level of the 4S motif. Phospho-specific antibodies and/or phospho-peptide mapping will be used to elucidate the The 4S motif of Cdx2 is highly conserved among mammals but is neither present in the two other proteins of the mammalian Cdx family, Cdx1 and Cdx4, nor in any Caudal-related protein throughout the animal kingdom, suggesting that the regulation of Cdx2 via the 4S motif has been acquired quite recently during the evolution of mammals. The 4S motif of Cdx2 contains four evenly spaced serines, in a similar arrangement to those controlling phosphorylation-dependent polyubiquitination and degradation of b-catenin. These serines within b-catenin are phosphorylated by a number of kinases among which is CDK2 (Park et al., 2004) . Here we show that, although the 4S motif is required for phosphorylation of Cdx2 by several kinases in vitro, only CDK2 acts in vivo, as assessed using a dominantnegative mutant and a pharmacological inhibitor of this kinase. In agreement with these results, an interaction between Cdx2 and CDK2 in GST pull-down assays was recently shown but no phosphorylation site was identified (Boulanger et al., 2005) . Our study indicates that the Cdx2 protein can be polyubiquitinated and degraded by the proteasome pathway and that the 4S>A mutant is much less efficiently ubiquitinated and degraded than wild-type protein. Collectively, these data support that, like for b-catenin, phosphorylation at the 4S motif is a signal for polyubiquitination, which subsequently directs Cdx2 to the proteasome degradation pathway. The stabilization of Cdx2 when phosphorylation is compromised at the level of the 4S motif did not significantly alter the nucleo-cytoplasmic distribution of Cdx2 (Supplementary information Figure 3 ). However, it stimulated the overall Cdx2 transcriptional activity measured on downstream target genes by promoter-luciferase assays and RT-PCR. Although it is likely that increased transcriptional activity is related to higher Cdx2 stability when phosphorylation is prevented in the 4S>A mutant, further studies will investigate whether phosphorylation at the 4S site also controls the specific activity of this transcription factor.
Phosphorylation-dependent polyubiquitination is an important regulatory mechanism for many proteins. We found that preventing phosphorylation of the 4S motif of Cdx2 decreased its ability to suppress colony formation. This may seem puzzling, given the enhanced transcriptional activity displayed by the same 4S>A mutant. However, it is conceivable that despite immediate positive transcriptional effects generated by enhanced stability, lack of controlled degradation jeopardizes Cdx2 function in the long term. In addition, the ability of Cdx2 to reduce colony formation may be mediated by target genes related rather to growth suppression or apoptosis than to intestinal differentiation. Transcriptional activation of these target genes, which remain to be identified, may be differently affected by Cdx2 phosphorylation status compared to standard intestinal differentiation genes.
In the continuously renewed gut epithelium, Cdx2 protein is expressed in most epithelial cells. However, its level is lower in the small intestinal crypts where cells are proliferating compared to the differentiated cells of the villi, and there is also an increasing bottom-up gradient of Cdx2 in the distal colon epithelium. It is therefore likely that sustained CDK2 activity in the proliferating cells controls Cdx2 levels in the crypts, via phosphorylation of the 4S motif and subsequent polyubiquitination and degradation of the protein. CDK2 may also participate to the decline of Cdx2 generally observed in the growing colorectal tumors. Hence this work Figure 6 The 4S motif is important for Cdx2 colony suppressing activity. HCT 116 were transfected with empty expression vector (À) or the indicated Flag-tagged Cdx2-expressing vector (WT or 4S>A) and selected after 48 h with G418. After 2 weeks, colonies formed were stained with Giemsa. (a) Representative dishes showing that the Cdx2 mutant 4S>A is not as efficient as wildtype Cdx2 in reducing colony formation. (b) Quantification showing the average colony suppressing activity ( þ /À standard deviation) in three independent experiments with each performed in triplicates. The number of colonies formed upon transfection of empty expression vector was set at 100% for each experiment to facilitate comparison between experiments. ** indicates statistically significant differences tested by one-way analysis of variance followed by a Newman-Keuls test by pairs uncovers a new mechanism of regulation of the Cdx2 tumor suppressor, which may be of importance for intestinal development and cancer.
Materials and methods
Construction of plasmids encoding mutant forms of Cdx2
pCB6-HA-Cdx2 has been described (Gautier-Stein et al., 2003) and was used as template to generate the following HA-tagged Cdx2 mutants with the QuickChange site-directed mutagenesis kit (BD Biosciences, Clontech): S12A, S17A, S60G (according to Rings et al., 2001) , S178A, T221A, S281A, S285A, S289A, S293A (serines (S) or threonines (T) were replaced by alanines (A) or glycines (G)), 3S>A (S281, 285, 289 replaced by A) and 4S>A (S281, 285, 289 and 293 replaced by A). To generate pCB6-Flag2-Cdx2, a sense oligonucleotide (CTA GGC GAT TAC AAG GAT GAC GAC GAT AAG) and the corresponding antisense oligonucleotide were annealed. This doublestranded DNA fragment encoding the Flag tag was inserted into the NheI site created in pCdx2-S (Lorentz et al., 1997; Gautier-Stein et al., 2003) . pCB6-Flag2-Cdx2 was then used as template to create the subsequent Flag-tagged Cdx2 mutants with the QuickChange kit: S281A, 3S>A, 4S>A, S281E (S281 replaced by glutamic acid (E)), 2S>E (S281 and 285 replaced by E) and 4S>E (S281, 285, 289 and 293 replaced by E). Each new construct was checked by sequencing. Information about other plasmids is provided in Supplementary information.
Cellular and biochemical procedures
Cell culture, transfection, colony formation assay, as well as Western blot, phosphatase or kinase assays, ubiquitination assay, real-time RT-PCR and immunofluorescence were performed according to standard protocols. Details can be found in Supplementary information.
